Keywords: synthelabo, focus, cns, cardiovascular, internal, medicine, its

Synthelabo R&D focus on CNS, cardiovascular and internal medicine

Article | 22 April 1999

Print This

In its annual report for 1998, French drugmaker Synthelabo notes thatits research is targeted on three fields: the central nervous system, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in